Golden Goose Financial News | MEIZHONGJIAHE (02453) stock price soared, triggering the market adjustment mechanism and entering a cooling-off period. As of the time of publication, it increased by 29.45%, reported at HKD 14.24, with a trading volume of HKD 16.861 million.
Recently, ten departments including the Guangzhou Medical Security Bureau jointly issued the "Notice on Several Measures for Building an Open Multi-Level Medical Insurance System in Guangzhou" (hereinafter referred to as "Notice"). This new policy works from three dimensions with a total of seventeen measures aimed at supporting the effective connection and supplementation of commercial health Insurance and the basic medical guarantee system, promoting the innovative design, development, and optimization of commercial health insurance products, and further optimizing public services of commercial health insurance, fully dedicated to building a multi-level medical insurance system.
The company's Guangzhou Taihe Cancer Hospital, located in the International Medical and Health Demonstration Zone of Sun Yat-sen University within the Nansha Guangdong Knowledge City in Huangpu District, Guangzhou, is a tertiary cancer specialist hospital and has been included in the category of Medical Insurance designated medical institutions. The release of the "Notice" holds extremely far-reaching and significant implications for Guangzhou Taihe Cancer Hospital, especially for its proton therapy center. Its parent company, MEIZHONGJIAHE, is expected to seize this opportunity to welcome broader development prospects.
